Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05019547
Other study ID # ATADEK 2021 - 15
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 1, 2021
Est. completion date December 10, 2021

Study information

Verified date December 2021
Source Acibadem University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Our aim in this study is to translate the Inflammatory Arthritis Facilitators and Barriers to Physical Activity (IFAB) Questionnaire which was developed to determine the factors that facilitate and prevent individuals for physical activity for patients with inflammatory arthritis into Turkish language. Also, our aim is to evaluate the validity and reliability of the IFAB Questionnaire in the Turkish population, and to perform a cultural adaptation if necessary at the same time. Determining the factors that facilitate and prevent individuals for physical activity interventions with rheumatic diseases and then designing physical activity programs considering these factors may play an important role in reducing the symptoms caused by the disease and increasing their quality of life.


Recruitment information / eligibility

Status Completed
Enrollment 93
Est. completion date December 10, 2021
Est. primary completion date December 10, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Being 18 years or older, - Diagnosed with Axial Spondyloarthritis by an experienced rheumatologist - To have the neurological competence and cognitive level to answer the scale questions. Exclusion Criteria: - Having a rheumatological disease other than Axial Spondyloarthritis , - Using an assistive device for walking. - Any verbal or written communication problems in Turkish,

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Determining Barriers and Facilitators of Physical Activity
Determining Barriers and Facilitators of Physical Activity

Locations

Country Name City State
Turkey Haydarpasa Numune Research and Training Hospital Istanbul

Sponsors (1)

Lead Sponsor Collaborator
Acibadem University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Inflammatory Arthritis Barriers and Facilitators to Physical Activity Questionnaire (IFAB) The IFAB Questionnaire was developed by Davergne et al. in 2020 and aims to evaluate the factors that facilitate or prevent physical activity in individuals with inflammatory arthritis. The IFAB questionnaire consists of 10 items. Of these 10 items, 4 were identified as potential barriers or facilitators, 3 as only barriers and 3 as only facilitators. The participant is asked to rate how much the item facilitates or prevents from physical activity between 0 and 10, "0" has no effect on physical activity, and "10" has maximum (negative or positive) effect on physical activity. A high score from the questionnaire indicates that the facilitators are at a high level and the barriers are at a low level. 1 day
Primary The Exercise Benefits or Barriers Scale The Exercise Benefits and Barriers Scale has been developed by Sechrist et al. and the Turkish validity and reliability studies were conducted by Ortabag et al. This scale will be used to evaluate criterion validity which evaluates the benefits and barriers of exercise perceived by the individual on a 4-point Likert-type scale with 43 questions. Scoring is performed as barrier score, benefit score and total score. A low score means less perceived barriers to exercise and greater benefits. 1 day
Primary International Physical Activity Questionnaire - Short Form The physical activity level reported by the participants will be evaluated with the International Physical Activity Questionnaire - Short Form. The International Physical Activity Questionnaire - Short Form questions the time spent walking, moderate and vigorous activities, and sitting with 7 questions. The duration (minutes) and frequency (days) of each activity are questioned. The physical activity levels of the participants will be classified as inactive, minimally active and very active according to the results. 1 day
Secondary Hospital Anxiety and Depression Scale (HADS) The HADS scale was developed to assess anxiety and depression in individuals without psychiatric illness. Of the 14-item questionnaire, 7 questions assess depression and 7 questions assess anxiety and each response consists of a four-point rating scale (0 to 3); a higher score indicates a worse condition.For each subscale the total score is at most 21. 1 day
Secondary Health Assessment Questionnaire - Disability Index This questionnaire evaluates the level of functional disability in patients with rheumatological disease over 20 questions. It determines the level of difficulty of the person during the activities that are most frequently performed in daily life such as dressing, eating, hygiene, walking, sitting up, reaching and grasping. A high score indicates a low level of functionality. 1 day
See also
  Status Clinical Trial Phase
Completed NCT05031767 - Remote Monitoring of Axial Spondyloarthritis N/A
Completed NCT05162937 - to Evaluate the Preliminary Efficacy and Safety of GR1501 Injection in Patients With Active Axial Spondyloarthritis Phase 2
Completed NCT03622658 - Efficacy and Safety of Namilumab for Moderate-to-severe Axial Spondyloarthritis Phase 2
Completed NCT03248518 - Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases N/A
Terminated NCT02437162 - A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNFα Naive Participants With Active Radiographic Axial Spondyloarthritis Phase 3
Enrolling by invitation NCT06072859 - The Impact of Simulated Forest Immersion Therapy on Pain and Anxiety in Patients Axial Spondyloarthritis (axSpA) N/A
Completed NCT02552212 - Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of AS Phase 3
Active, not recruiting NCT02687620 - Does Immunogenicity Have an Influence on the Efficacy of Anti-TNF Therapy in Patients With AS: An Inception Cohort Study
Active, not recruiting NCT01944163 - The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain N/A
Completed NCT00844805 - Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1) Phase 3
Terminated NCT02897115 - A Study Treating Participants With Early Axial Spondyloarthritis (axSpA) Taking an Intense Treatment Approach Versus Routine Treatment Phase 4
Recruiting NCT03738956 - Safety and Efficacy of Tofacitinib in the Treatment of NSAID Refractory Axial Spondyloarthritis:A Clinical Trial Phase 2/Phase 3
Enrolling by invitation NCT02962479 - Is the Human Microbiome Altered in Patients With Axial Spondyloarthritis? N/A
Completed NCT04485078 - Investigation of Central Sensitization Frequency and Related Factors in Axial Spondyloarthritis Patients
Recruiting NCT05812157 - Optimizing Anti-IL17 Antibody Therapy by Associating Fiber Supplementation to Correct Treatment-aggravated Gut Dysbiosis in Axial Spondyloarthritis - RESPOND-IL17 N/A
Completed NCT03039088 - PREDICT-SpA - French Epidemiological Study of the Evaluation of the Impact of Fibromyalgia in the TNF Alpha Treatment Effect in Axial Spondyloarthritis in Both Anti-TNF naïve and - Experienced Patients
Completed NCT04368494 - Exercise Therapy in Patients With Axial Spondyloarthritis N/A
Completed NCT03270501 - Efficacy of Golimumab in Early Axial Spondyloarthritis in Relation to Gut Inflammation Phase 3
Completed NCT03043846 - Treat to Target Trial in Axial Spondylo Arthritis : The TICOSPA (Tight Control in Spondyloarthritis)
Recruiting NCT02956824 - Incidence of MRI Sacro-Iliac Joint Anomalies in Young Women N/A